Paul Tudor Jones's VOR Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 19,620 shares of Vor Biopharma Inc. (VOR) worth $361,204, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in VOR for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q2 2026, reducing 132,951 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Vor Biopharma (VOR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vor Biopharma (VOR) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -132,951 | Reduce 87.14% | 19,620 | $18.41 |
| Q1 2026 | -15,102 | Reduce 9.01% | 152,571 | $17.84 |
| Q4 2025 | +167,673 | New Buy | 167,673 | $13.08 |
Paul Tudor Jones's Vor Biopharma Investment FAQs
Paul Tudor Jones first purchased Vor Biopharma Inc. (VOR) in Q4 2025, acquiring 167,673 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Vor Biopharma Inc. (VOR) for 3 quarters since Q4 2025.
Paul Tudor Jones's largest addition to Vor Biopharma Inc. (VOR) was in Q4 2025, adding 167,673 shares worth $2.19 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 19,620 shares of Vor Biopharma Inc. (VOR), valued at approximately $361,204.
As of the Q2 2026 filing, Vor Biopharma Inc. (VOR) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Vor Biopharma Inc. (VOR) was 167,673 shares, as reported at the end of Q4 2025.